Red nose: primary cutaneous marginal zone B-cell lymphoma.
Rosmaninho
Aristóteles
A
Department of Dermatology, Centro Hospitalar do Porto-HSA, Oporto, Portugal. mancini_manu@yahoo.com
Alves
Rosário
R
Lima
Margarida
M
Lobo
Inês
I
Amorim
Isabel
I
Selores
Manuela
M
D000287:Administration, Topical; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007371:Interferon-gamma / Q000008:administration & dosage; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy / Q000473:pathology*; D008795:Metronidazole / Q000627:therapeutic use; D008911:Minocycline / Q000627:therapeutic use; D009666:Nose / Q000473:pathology*; D011994:Recombinant Proteins; D012393:Rosacea / Q000150:complications / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D008795:Metronidazole; D007371:Interferon-gamma; D008911:Minocycline